Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability, including opaque methodologies, synthetic controls, and the limits of ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...

New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

Discover strategies to overcome sample preparation challenges in clinical proteomics, optimizing workflows for researchers.

They live in our houses, drink our water and even sleep in our beds. Cats have become an integral part of many households and ...

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

The Minns Labor Government is providing a funding boost to an Australian-first alliance that’s fast-tracking cancer patients across NSW onto potentially life-saving early-stage clinical trials.

Polyrizon Ltd. (Nasdaq: PLRZ) ('Polyrizon” or the 'Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a ...